Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma

Area of Science:

• Oncology
• Genetics
• Pathology

Background:

• Sarcomas are rare mesenchymal tumors with diverse morphology and molecular profiles.
• Molecular studies are crucial for refining sarcoma classification and identifying diagnostic, prognostic, and predictive markers.
• Understanding molecular alterations is key to improving sarcoma patient outcomes.

Purpose of the Study:

• To summarize major molecular mechanisms in sarcoma pathogenesis.
• To present clinically relevant molecular markers for sarcoma diagnosis, prognosis, and therapy prediction.
• To illustrate these mechanisms with representative sarcoma subtypes.

Main Methods:

• Review of molecular mechanisms underlying sarcoma development.
• Identification and discussion of key molecular alterations in specific sarcoma types.
• Correlation of molecular findings with diagnostic, prognostic, and predictive applications.

Main Results:

• Five major molecular alterations driving sarcoma pathogenesis were identified: chimeric transcription factors, abnormal kinase signaling, epigenetic deregulation, focal copy number alterations, and extreme genomic instability.
• These alterations are exemplified in various sarcoma types, including vascular tumors, gastrointestinal stromal tumors, chondrosarcomas, dedifferentiated liposarcomas, and osteosarcomas.
• Clinically useful molecular markers derived from these alterations are presented.

Conclusions:

• Molecular insights significantly enhance sarcoma classification and clinical management.
• Specific molecular markers offer valuable tools for diagnosis, prognosis, and predicting therapeutic response in sarcomas.
• Continued molecular research is essential for advancing sarcoma treatment and patient care.